Korean Distributor Seeks Marketing Approval For Cephalon’s Trisenox In Korea
This article was originally published in PharmAsia News
Executive Summary
SEOUL- South Korean pharmaceutical importer and distributor BL&H will bring in Cephalon's arsenic trioxide product Trisenox injection from Japan's Nippon Shinyaku to sell the product to about 250 South Koreans estimated affected by refractory acute promyelocytic leukemia